SNPMiner Trials (Home Page)
Report for Clinical Trial NCT01025024
Developed by Shray Alag, 2020.
SNP Clinical Trial Gene
A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the
glaucoma patients and the normal control will be performed to find genetic marker for primary
open angle glaucoma.
NCT01025024 Single-nucleotide Polymorphism (SNP) for Glaucoma
1 Interventions
Name: SNP analysis of the DNA
Description: SNP analysis of the DNA obtained from peripheral blood sampleType: Genetic
Normal control POAG group
Primary Outcomes
Measure: genotyping for the SNP associated with primary open angle glaucoma
Time: one year
Secondary Outcomes
Measure: genotyping for rs7961953 and additional SNPs in TMTC2 from other linkage disequilibrium patterns
Time: one year
Time Perspective: Prospective
Case Control
There is one SNP
SNPs
genotyping for rs7961953 and additional SNPs in TMTC2 from other linkage disequilibrium patterns.
HPO Nodes